In this article, we will take a look at Maple Leaf Green World Inc. (TSX.V: MGW) (OTCQB: MGWFF) and its presence in three of the largest medical and recreational cannabis markets throughout North America where it has established cultivation operations.
CFN Media’s Mike Elliott recently discussed Maple Leaf Green World’s significant potential in an exclusive video interview with VP of Business Development Bill Monroe:
Maple Leaf Green World operates a joint venture with a non-profit co-op collective located near Palm Springs, CA. The company built two greenhouses on a 20 acre property that it purchased and currently harvests between 100 and 150 pounds of medical marijuana six times per year in a continuous cycle. With enough space for 100 greenhouses, the company has ample opportunities to expand with recreational legalization in the works.
Nevada voters also voted to legalize recreational marijuana in one of the most promising tourism markets in the country. With over 40 million tourists per year, Las Vegas has become a popular destination for both Americans and international tourists. The state’s reciprocity laws already enable out-of-state medical marijuana card holders to access the drug, but recreational legalization could make the state a top-3 consumer.
Maple Leaf Green World is in the process of acquiring a cultivation license in Nevada through its acquisition of BioNeva Innovations of Henderson LLC, which owns and operates a 33,500 square foot cultivation facility that’s pending approval in Henderson – just 15 minutes from Las Vegas. The move could provide the company with a valuable footprint in the Nevada market that’s in close proximity to Las Vegas’ significant tourist economy.
Near-term Canadian Approval
Canada legalized the cultivation of medical cannabis on a national level back in July 2013 with the Marihuana for Medical Purposes Regulations (MMPR). Since then, the government has approved nearly 40 licensed producers and amended the rules to become the Access to Cannabis for Medical Purposes Regulations (ACMPR). Prime Minister Justin Trudeau’s election also set forth the path to recreational legalization over the coming year or two.
Maple Leaf Green World is in the last stage of approval (Stage 5) to become a licensed producer under the ACMPR program. With an 80,000 square foot facility under construction, the company could become one of the largest licensed producers in the market. The company also has the potential to build up to 300,000 square foot of greenhouses on properties that it has under its control if expansion makes sense down the road.
Maple Leaf Green World Inc. (TSX.V: MGW) (OTCQB: MGWFF) represents an intriguing investment opportunity in the North American cannabis industry. With a presence in both U.S. and Canadian markets, the company provides diversified exposure to the cultivation side of the industry, while its modest C$82 million market capitalization makes it a potential value.
Meanwhile, two longstanding cannabis partners ended their relationship.
Trulieve to donate $20,000 in scholarship funding and $15,000 to support leadership development
Trulieve Cannabis Corp . (CSE: TRUL) (OTC: TCNNF), a leading and top-performing cannabis company in the United States today announced a new partnership with the Thurgood Marshall College Fund (TMCF), the nation’s largest organization exclusively representing the Black College Community. Trulieve will donate $20,000 to help fund several college scholarships awarded to students who are attending one of the organization’s member-schools as part of Trulieve’s diversity, equity, and inclusion initiatives. The $15,000 in talent funding is earmarked to support TMCF’s internship program, reaching a diverse talent pool of students and alumni from their 47 member-schools to provide immersive experiences at Trulieve.
The new dispensary expands patient access to Florida’s largest inventory of medical cannabis products
Trulieve Cannabis Corp. (CSE: TRUL) (OTCQX: TCNNF) (“Trulieve” or “the Company”), a leading and top-performing cannabis company based in the United States announced today the opening of a brand-new Florida dispensary, the Company’s 80th nationwide. The new location marks the Company’s first in Tamarac and third in Broward County expanding patient access to Florida’s largest and broadest assortment of high-quality medical cannabis products.
Revive Therapeutics Provides Update on FDA Phase 3 Clinical Trial for Bucillamine in COVID-19 with Planned Completion and Emergency Use Authorization Request
Revive Therapeutics Ltd. (“Revive” or the “Company”) (CSE: RVV, USA: RVVTF), a specialty life sciences company focused on the research and development of therapeutics for medical needs and rare disorders, is pleased to announce an update on the Company’s U.S. Food & Drug Administration (“FDA”) Phase 3 clinical trial (the “Study”) to evaluate the safety and efficacy of Bucillamine in patients with mild to moderate COVID-19.
With its recent $23 million dollar financing, the Company plans to aggressively expand from 14 clinical sites to up to 50 clinical sites to meet the next enrollment goals for the Study in Q2-2020. The Study is a randomized, double-blinded, placebo-controlled trial and the safety and efficacy data analyzed at each interim analysis timepoint of 210, 400, 600 and 800 completed patients are only made available to the Independent Data and Safety Monitoring Board (“DSMB”) for review and recommendations on continuation, stopping or changes to the conduct of the Study. In the event of any serious safety concerns, the DSMB would be notified to determine any risks and provide its recommendations. To date, in this initial 210 interim point there have been no serious safety concerns that required the DSMB to be notified.
HempFusion Wellness Inc. (TSX:CBD.U) (OTCQX:CBDHF) (FWB:8OO) (“HempFusion” or the “Company”), a leading health and wellness CBD company utilizing the power of whole-food hemp nutrition, is pleased to announce that its common shares have been approved for DTC full-service eligibility in the United States by the Depository Trust Company (“DTC”) and can now be both traded and serviced through DTC’s electronic book-entry system.
DTC is a subsidiary of the Depository Trust & Clearing Corp. (“DTCC”) that provides clearing and settlement services for the financial markets and settles the majority of securities transactions in the United States. This electronic method of clearing securities speeds up the receipt of stock and cash and thus accelerates the settlement process for investors and brokers, enabling the stock to be traded over a much wider selection of brokerage firms.